Stemnovate Limited

Stemnovate delivers precision drug discovery and disease modelling using advanced multiomics technologies—genetic sequencing, bioinformatics, and cellular reprogramming. Based in Cambridge, Stemnovate specialises in rare childhood diseases, enabling direct patient participation and bridging research with faster clinical translation.